Clinical Trial Update: European Trial of Free Light Chain Removal by Extended Haemodialysis in Cast Nephropathy [NA]

View source ↗

Summary

A European trial evaluating extended haemodialysis to remove free light chains in myeloma-associated cast nephropathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Myeloma Cast Nephropathy

Snippet

Sponsor: University Hospital Birmingham | Conditions: Multiple Myeloma, Cast Nephropathy | NA | Status: COMPLETED